Alphamab Oncology Company Profile, Contacts & Intelligence

Pharmaceutical Manufacturing苏州市, 江苏省, Cn27 employeesFounded 2015
1 contact with email or phone data1 with email data
Employees
27
Company source estimate
Reachable Contacts
1
Visible contacts with email or phone data
Contacts With Email
1
1 of 3 visible contacts

Alphamab Oncology Overview

Alphamab Oncology (Stock code: 9966.HK) is an innovative biopharmaceutical company focusing on oncology therapeutics. By leveraging its proprietary core technology platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payload, dual-payload antibody conjugation, and subcutaneous high concentration formulation for biologics, the Company has established a differentiated and globally competitive product portfolio, covering cutting-edge areas such as antibody-drug conjugates (ADCs), bispecific antibodies, and single-domain antibodies. The Company has one product approved for marketing (Envafolimab, the world's first subcutaneously injectable PD-(L)1 inhibitor), which has made a significant breakthrough in the convenience and accessibility of cancer treatment. Additionally, the Company has multiple bispecific antibodies and bispecific ADCs in clinical stage, while rapidly advancing the preclinical pipeline prioritizing bispecific ADCs and dual-payload ADCs. Multiple strategic collaborations based on innovative products or technology platforms have been established with partners such as CSPC, ArriVent, and Glenmark. Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs to benefit patients.

Headquarters
苏州市, 江苏省, Cn
Industry
Pharmaceutical Manufacturing
Founded
2015
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Alphamab Oncology Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

1 contact with contact data
1 with email data in the visible sample.

Alphamab Oncology People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Alphamab Oncology Workforce Composition

Seniority breakdown across 3 visible profiles.

Individual contributor
2
Director
1

Compare Similar Companies to Alphamab Oncology

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Innovent Biologics Pharmaceutical Manufacturing 832 View company
Luye Pharma Group Pharmaceutical Manufacturing 750 View company
Henlius Biotechnology Research 463 View company
Biocytogen Biotechnology Research 193 View company
Beacon Research Services 95 View company
ArriVent Biopharma Biotechnology Research 67 View company
MediLink Therapeutics Biotechnology Research 45 View company
BioRay Pharmaceutical Biotechnology Research 38 View company
AbTis | 앱티스 Biotechnology 16 View company
Hangzhou DAC Biotech Co., Ltd. Research 3 View company